(Q37851361)

English

Protective immunity against Chlamydia trachomatis genital infection induced by a vaccine based on the major outer membrane multi-epitope human papillomavirus major capsid protein L1.

scientific article published on 12 February 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Protective immunity against Chlamydia trachomatis genital infection induced by a vaccine based on the major outer membrane multi-epitope human papillomavirus major capsid protein L1. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Chlamydia trachomatis

0 references

Chlamydia trachomatis genital infection

1 reference

based on heuristic

inferred from title

author name string

Wen Xu

1

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Jianxiao Liu

2

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Wenci Gong

3

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Jun Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Shanli Zhu

5

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Lifang Zhang

6

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

language of work or name

0 references

publication date

12 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

2672-2678

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Ectopic pregnancies and reproductive capacity after Chlamydia trachomatis positive and negative test results: a historical follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

Incidence of genital Chlamydia trachomatis infection in the male partners attending an infertility clinic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

Effect of Chlamydia trachomatis coinfection on HIV shedding in genital tract secretions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

Chlamydia trachomatis infection as a risk factor for invasive cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

HPV16 L1 capsid protein expressed from viable adenovirus recombinants elicits neutralizing antibody in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

Papillomavirus virus-like particles as vehicles for the delivery of epitopes or genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

Synthetic peptides based on Chlamydia trachomatis antigens identify cytotoxic T lymphocyte responses in subjects from a trachoma-endemic population.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

A novel recombinant multisubunit vaccine against Chlamydia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

DNA vaccination with the major outer-membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

Optimum conditions for production and purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

Plasmacytoid dendritic cells are present in cervical carcinoma and become activated by human papillomavirus type 16 virus-like particles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

Papillomavirus virus-like particles induce cytokines characteristic of innate immune responses in plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

Interaction of papillomavirus virus-like particles with human myeloid antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

Physical interaction of human papillomavirus virus-like particles with immune cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

Interaction of Chlamydia trachomatis with mammalian cells is independent of host cell surface heparan sulfate glycosaminoglycans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

Human papillomavirus type 6b virus-like particles are able to activate the Ras-MAP kinase pathway and induce cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

GM-CSF transgene-based adjuvant allows the establishment of protective mucosal immunity following vaccination with inactivated Chlamydia trachomatis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

Development of a Chlamydia trachomatis bacterial ghost vaccine to fight human blindness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

The major outer membrane protein of a single Chlamydia trachomatis serovar can possess more than one serovar-specific epitope

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of the alpha6 integrin as a candidate receptor for papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.132

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2010.12.132

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37851361&oldid=2098279879"